Series C funding round for Vividion Therapeutics raising $140M in February 2021
Series C funding round for Vividion Therapeutics raising $140M in February 2021
| Investor | Firm Type | Partner |
|---|
Logos CapitalLEAD | Venture Capital | — |
Boxer CapitalLEAD | Venture Capital | — |
| Private | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private Equity | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$272M
Top Valuation
-
Vividion Therapeutics raised $140M in a Series C round.
The round was announced on 02/01/21.
The round was led by Aaron Davis, Graham Walmsley.